| Primary |
| Antibiotic Therapy |
14.0% |
| Cellulitis |
14.0% |
| Hypertension |
9.3% |
| Prophylaxis |
7.0% |
| Abscess Limb |
4.7% |
| Back Pain |
4.7% |
| Diabetes Mellitus |
4.7% |
| Erysipelas |
4.7% |
| Infection |
4.7% |
| Post Procedural Infection |
4.7% |
| Staphylococcal Infection |
4.7% |
| Wound Infection |
4.7% |
| Anticoagulant Therapy |
2.3% |
| Arthralgia |
2.3% |
| Arthritis Infective |
2.3% |
| Atrial Fibrillation |
2.3% |
| Contraception |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Impetigo |
2.3% |
|
| Vomiting |
12.0% |
| Rash |
8.0% |
| Rash Pruritic |
8.0% |
| Renal Failure Acute |
8.0% |
| Abortion Spontaneous |
4.0% |
| Anaphylactic Reaction |
4.0% |
| Angioedema |
4.0% |
| Blood Creatinine Increased |
4.0% |
| Blood Urea Increased |
4.0% |
| Clostridial Infection |
4.0% |
| Diarrhoea |
4.0% |
| Diarrhoea Haemorrhagic |
4.0% |
| Duodenal Ulcer Perforation |
4.0% |
| Epstein-barr Virus Infection |
4.0% |
| Gastritis |
4.0% |
| Insomnia |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Menstruation Irregular |
4.0% |
| Oral Discomfort |
4.0% |
| Overdose |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
41.1% |
| Diffuse Large B-cell Lymphoma |
20.9% |
| Antibiotic Therapy |
11.4% |
| Thrombophlebitis |
3.8% |
| Wound Infection |
3.8% |
| Breast Abscess |
2.5% |
| Hiv Infection |
1.9% |
| Prophylaxis |
1.9% |
| Abscess Limb |
1.3% |
| Ankylosing Spondylitis |
1.3% |
| Antibiotic Prophylaxis |
1.3% |
| Joint Injury |
1.3% |
| Joint Swelling |
1.3% |
| Joint Warmth |
1.3% |
| Otitis Media |
1.3% |
| Staphylococcal Infection |
1.3% |
| Contraception |
0.6% |
| Gingivitis |
0.6% |
| Hypertension |
0.6% |
| Limb Injury |
0.6% |
|
| Myoglobin Blood Increased |
14.8% |
| Thrombocytopenia |
11.1% |
| Leukocytoclastic Vasculitis |
7.4% |
| Rash |
7.4% |
| Sepsis |
7.4% |
| Syncope |
7.4% |
| Acute Myocardial Infarction |
3.7% |
| Blister |
3.7% |
| Dermatitis Allergic |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Hallucination |
3.7% |
| Nausea |
3.7% |
| Otitis Media |
3.7% |
| Pain |
3.7% |
| Pharyngeal Oedema |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Toxicity To Various Agents |
3.7% |
| White Blood Cell Count Increased |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.7% |
| Pain |
13.8% |
| Drug Use For Unknown Indication |
8.2% |
| Breast Cancer |
5.4% |
| Metastases To Bone |
5.3% |
| Depression |
4.0% |
| Prophylaxis |
3.4% |
| Hiv Infection |
3.2% |
| Hypertension |
3.0% |
| Infection |
2.5% |
| Cardiac Failure |
2.4% |
| Prostate Cancer |
2.4% |
| Restless Legs Syndrome |
2.4% |
| Multiple Myeloma |
2.1% |
| Muscle Spasms |
1.9% |
| Asthma |
1.7% |
| Bone Lesion |
1.7% |
| Upper Respiratory Tract Infection |
1.7% |
| B-cell Lymphoma |
1.6% |
| Nausea |
1.6% |
|
| Vomiting |
8.9% |
| Weight Decreased |
8.9% |
| Wheelchair User |
7.6% |
| Wound Infection Staphylococcal |
6.3% |
| X-ray Abnormal |
6.3% |
| Cerebrovascular Accident |
5.1% |
| Deep Vein Thrombosis |
5.1% |
| Renal Failure Acute |
5.1% |
| Rhabdomyolysis |
5.1% |
| Death |
3.8% |
| Dehydration |
3.8% |
| Drug Interaction |
3.8% |
| Grand Mal Convulsion |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Multiple Congenital Abnormalities |
3.8% |
| Pyrexia |
3.8% |
| Sepsis |
3.8% |
| Thrombophlebitis Superficial |
3.8% |
| Trismus |
3.8% |
| Urinary Incontinence |
3.8% |
|
| Interacting |
| Cerebrovascular Accident |
70.6% |
| Candida Infection |
5.9% |
| Prophylaxis |
5.9% |
| Psoriasis |
5.9% |
| Staphylococcal Infection |
2.9% |
| Urinary Tract Infection |
2.9% |
| Thrombosis |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Erysipelas |
1.0% |
| Pain |
1.0% |
|
| International Normalised Ratio Increased |
42.9% |
| Blood Urea Increased |
28.6% |
| Gastrointestinal Disorder |
14.3% |
| Pruritus |
14.3% |
|
